These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2927242)

  • 1. Effects of caerulein + haloperidol on amphetamine-induced locomotor stereotypy in rats.
    Mueller K; Peel JL; Rewey KL
    Life Sci; 1989; 44(11):717-24. PubMed ID: 2927242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting reduction of amphetamine-induced hyperactivity in rats after combined administration of caerulein with haloperidol.
    Matsubara K; Matsushita A
    Eur J Pharmacol; 1984 May; 101(1-2):157-8. PubMed ID: 6745317
    [No Abstract]   [Full Text] [Related]  

  • 3. Locomotor stereotypy is produced by methylphenidate and amfonelic acid and reduced by haloperidol but not clozapine or thioridazine.
    Mueller K
    Pharmacol Biochem Behav; 1993 May; 45(1):71-6. PubMed ID: 8100075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Endorphin involvement in the antidopaminergic effect of caerulein.
    Matsubara K; Matsushita A
    Jpn J Pharmacol; 1986 Mar; 40(3):417-22. PubMed ID: 2940395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of the central nervous system in long-term effect of caerulein on amphetamine-induced hyperactivity in rats.
    Matsubara K; Matsushita A
    Jpn J Pharmacol; 1985 Nov; 39(3):317-21. PubMed ID: 4094180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of amphetamine-induced locomotor stereotypy in an open field.
    Mueller K; Kunko PM; Whiteside D; Haskett C
    Psychopharmacology (Berl); 1989; 99(4):501-7. PubMed ID: 2594917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of caerulein with haloperidol on monoamine contents in rat brain regions treated with methamphetamine.
    Hashimoto M; Hirai T; Oguchi K; Yasuhara H
    Jpn J Pharmacol; 1986 May; 41(1):127-30. PubMed ID: 3735809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential cataleptogenic and antistereotypic effects of caerulein and haloperidol.
    Zetler G
    Neuropharmacology; 1981 Jul; 20(7):681-6. PubMed ID: 7195998
    [No Abstract]   [Full Text] [Related]  

  • 9. Similar behavioral and biochemical effects of long-term haloperidol and caerulein treatment in albino mice.
    Vasar E; Allikmets L; Soosaar A; Lang A
    Pharmacol Biochem Behav; 1990 Apr; 35(4):855-9. PubMed ID: 2111914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of phenamine and haloperidol on stereotyped behavior in response to electric stimulation of the substantia nigra in cats].
    Arushanian EB; Tolpyshev BA
    Biull Eksp Biol Med; 1981 Oct; 91(10):444-7. PubMed ID: 7198491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine stereotypy in cats and neurotransmitter interactions in the caudate nucleus. I. Effects of intracaudate injections of haloperidol, GABA and bicuculline.
    Moyanova SG; Rousseva SP
    Acta Physiol Pharmacol Bulg; 1989; 15(1):54-62. PubMed ID: 2570502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801.
    Karler R; Calder LD; Chaudhry IA; Turkanis SA
    Life Sci; 1989; 45(7):599-606. PubMed ID: 2671566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine.
    Jelovac N; Sikirić P; Rucman R; Petek M; Perović D; Konjevoda P; Marović A; Seiwerth S; Grabarević Z; Sumajstorcić J; Dodig G; Perić J
    Biol Psychiatry; 1998 Apr; 43(7):511-9. PubMed ID: 9547930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Another look at amphetamine-induced stereotyped locomotor activity in rats using a new statistic to measure locomotor stereotypy.
    Mueller K; Hollingsworth EM; Cross DR
    Psychopharmacology (Berl); 1989; 97(1):74-9. PubMed ID: 2496430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy.
    Tschanz JT; Rebec GV
    Pharmacol Biochem Behav; 1988 Nov; 31(3):519-22. PubMed ID: 3251235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of fasting on the stereotyped behaviour induced by amphetamine and by apomorphine in the albino rat.
    Fuenmayor LD; Diaz S
    Eur J Pharmacol; 1984 Mar; 99(2-3):153-8. PubMed ID: 6539708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the long-lasting antagonistic effect of caerulein on amphetamine hyperactivity in rats.
    Matsubara K; Matsushita A
    Jpn J Pharmacol; 1985 Aug; 38(4):381-90. PubMed ID: 4068379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel procedure for dissociating the anatomical bases of the behavioral effects of amphetamine.
    Towell A; Willner P; Muscat R
    Pharmacol Biochem Behav; 1987 Nov; 28(3):423-6. PubMed ID: 3685080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the mechanism of the long-lasting antagonistic effect of caerulein on amphetamine-induced hyperactivity in rats.
    Matsubara K; Matsushita A
    Gen Pharmacol; 1986; 17(1):13-7. PubMed ID: 2936646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.